Skip to content

[Webinar] Lumina 3D unleashed: How imaging automation eliminates bottlenecks | July 22, 11:00 AM Pacific

Ischemic stroke

The gold standard in stroke care

Trusted by leading healthcare providers worldwide, our ischemic stroke solutions deliver unmatched clinical depth. Used in patient selection for the landmark trials that shaped the AHA’s updated guidelines, RapidAI is redefining what’s possible in stroke diagnosis and treatment.

An artistic twist of driftwood resembling a unique, abstract tree sculpture with intricate branches and roots.

Introducing Lumina 3D™ by RapidAI

Access advanced 3D imaging reconstruction minutes after a CTA scan.

See more, sooner: Visualize the aortic arch, carotid tortuosity, and neurovasculature from your mobile device
Plan with precision: Confidently assess anatomy and inform access strategies anytime, anywhere
Enhance procedural clarity: Leverage detailed 3D views to support first-pass reperfusion

Ischemic Stroke Solution Features

Products

NCCT Stroke

ASPECTS

Hypodensity

Rapid LVO

Rapid CTA

Perfusion Imaging

AngioFlow

CT scan image of a brain with a note indicating a suspected left ventricular outflow obstruction (LVO) on NCCT. Mobile app displayed.

NCCT Product

Rapid NCCT Stroke

Improve equity of care with the only FDA-cleared NCCT imaging solution for suspected LVO

Make early and time-sensitive treatment and transfer decisions
Enable stroke detection at any center, for equitable care across the network
Expedite time between CT and CTA scans with prompt LVO notifications

<3 min

image analysis

55%

increase in sensitivity

18 min¹

faster with Rapid vs no Rapid in time-to-decision

A smartphone displays patient data alongside MRI brain scans, highlighting regions affected by ischemia with a scoring system on the right.

NCCT Product

Rapid ASPECTS

The first neuro-imaging AI solution shown to improve clinician diagnostic accuracy

Determine thrombectomy eligibility with an automated ASPECT score
Quickly visualize regions of asymmetry and review measurements of ischemic change
Help every reader be an expert – increase reader reliability and reduce intra-reader variability

Only 1

Only solution to provide automated ASPECTS score

< 2 min

< 2 minutes - standardized ASPECT score delivered

10%

10% improvement in reader accuracy

Hypodensity product image

NCCT Product

Rapid Hypodensity

The first software to help identify and quantify potential subacute infarction volumes across all brain regions

Easily visualize the extent and region of ischemia, differentiating between subacute and chronic lesions
Determine the best treatment decisions for large core patients
Get NCCT results in minutes, including regions with HU reductions between 4-12

First and only

First and only solution to provide automated quantification of hypodense tissue after an ischemic event

lvo-product-device

CTA Product

Rapid LVO

Quickly identify suspected LVOs & streamline patient triage.

Detect suspected LVOs accurately in the ICA and MCA-M1
Receive automated notifications when an LVO is suspected after CTA scan
Access results and source files across the network via PACS, email, web, and mobile app

97%

Sensitivity

96%

Specificity

A smartphone displays a vascular image with color-coded blood vessel density scale, highlighting areas with varied blood flow.

CTA Product

Rapid CTA

Enhance your visibility of distal occlusions and collateral flow with vessel density asymmetry.

Identify the area of occlusion and quantify the impacted vasculature with color-coded overlays
Automatically assess collateral vessels to inform treatment and prognostic decisions
Enhance your view with 3D reconstructions and multi-angle perspectives for precise stroke diagnosis

53%

MeVOs Identified with Rapid Ischemic Stroke Solution (Rapid LVO + Rapid CTA Vessel Density)³

95%

PPV for LVOs⁴

26%

reduction in CTA-to-Groin puncture⁵

Mobile interface displaying CBF and Tmax imaging results, highlighting critical areas for potential thrombolysis treatment.

CTP Product

Rapid Perfusion Imaging

The only perfusion imaging solution cleared in the U.S. with a mechanical thrombectomy indication.

Identify salvageable brain tissue with quantified, color-coded maps of ischemic core and penumbra mismatch.
Project ischemic core growth and collateral capability with hypoperfusion.
Consolidate a wide range of complex data into easily visualized outputs of cerebral blood flow (CBF), cerebral blood volume (CBV), transit times (MTT and Tmax) with integrated scan quality controls.
Rapid CTP has been the core technology at the center of many of the pivotal stroke trials and continues to be the gold standard in 75% of all Comprehensive Stroke Centers in the US.

>10

>10 Clinical trials. Validate Rapid CTP, including EXTEND, SWIFT-PRIME, DAWN, EXTEND-IA, AND DEFUSE 3.

51%

increase in Mechanical Thrombectomy procedures post RapidAI implementation⁶

90/95%

90/95% Sen/Spec for distal vessel occlusion⁷

angio-flow-ipad-device

CTP Product

AngioFlow by RapidAI^TM

Accelerate time to treatment with perfusion imaging in the angio suite

Take the patient directly to the angio suite and review qualitative assessments
Reduce the need for re-imaging ahead of surgery to save time and resources while improving workflow
Review color-coded brain regions with reduced CBF/CBV and delayed contrast arrival in the angio suite
Identify irreversibly injured tissue and assess successful reperfusion directly on the C-Arm

35 min

time saved with direct-to-angio LVO patient routing⁸

26%

mRS improvement⁹

How it works: fast, connected, and ready for action

From scan to intervention, RapidAI keeps the entire team
informed + connected.

Scan initiated: After a scan, our deep clinical AI automatically processes the images within moments.
Prompt results: Results are instantly delivered to the care team—accessible through the mobile app, PACS, and integrated systems
Real-time collaboration: Teams can discuss findings and next steps directly within the platform
Coordinated action: When intervention is needed, the team can be quickly activated to deliver care

Clinical Solutions

Expand the reach of your expertise

Our full suite of AI-driven solutions is ready to build a game-changing AI program that goes beyond the walls of your hospital.

Two horizontal CT brain scans showing cross-sections of the brain, highlighting structures and potential abnormalities.

Neurovascular

Our history in neurovascular AI goes as deep as our algorithms.

cardiac-vascular-NEW

Vascular

Let us help you face the challenges of PE care head-on.

Black and white brain scan image

Radiology

Bring clarity and speed to every read.

Sources:

1. From a simulated study - Improved Time to Triage decision by emergency physicians using RAPID noncontrast CT stroke platform for acute stroke patients

2. Time is Brain : OPTIMIZING PROTOCOLS FOR STROKE THROMBECTOMY

3. (Sowlat, Mohammad Mahdi, et al. "Abstract WMP66: Detecting Medium Vessel Occlusions and Collateral Assessment With Multimodality AI Approach." Stroke 55.Suppl_1 (2024): AWMP66-AWMP66.)

4. (Amukotuwa, Shalini A et al. “Fast Automatic Detection of Large Vessel Occlusions on CT Angiography.” Stroke vol. 50,12 (2019): 3431-3438. doi:10.1161/STROKEAHA.119.027076

5. (Amukotuwa, Shalini A et al. “Fast Automatic Detection of Large Vessel Occlusions on CT Angiography.” Stroke vol. 50,12 (2019): 3431-3438. doi:10.1161/STROKEAHA.119.027076)

6. (Malisch, Tim W., et al. "Abstract WP126: Improved Stroke Outcomes Following Implementation of RapidAI Platform at Ascension-Illinois." Stroke 55.Suppl_1 (2024): AWP126-AWP126.)

7. (Amukotuwa, S A et al. “Time-to-Maximum of the Tissue Residue Function Improves Diagnostic Performance for Detecting Distal Vessel Occlusions on CT Angiography.” AJNR. American journal of neuroradiology vol. 42,1 (2021): 65-72. doi:10.3174/ajnr.A6891)

8. Desai, Shashvat M., et al. "Direct transfer to the neuroangiography suite for patients with stroke." Stroke 54.6 (2023): 1674-1684.

9. Galecio-Castillo, Milagros, et al. "Direct to angiosuite strategy versus standard workflow triage for endovascular therapy: systematic review and meta-analysis." Journal of neurointerventional surgery 15.e1 (2023): e17-e25.